Log In
Print
BCIQ
Print
Print this Print this
 

Adasuve (Staccato loxapine) (formerly AZ-004)

  Manage Alerts
Collapse Summary General Information
Company Alexza Pharmaceuticals Inc.
DescriptionLoxapine delivered by Staccato system inhaler
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT2) receptor
Mechanism of ActionDopamine D2 receptor antagonist; Serotonin (5-HT2) receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today